InvestorsHub Logo
Followers 2
Posts 927
Boards Moderated 0
Alias Born 09/27/2005

Re: JAZZ ONE post# 12865

Tuesday, 03/25/2008 11:21:47 PM

Tuesday, March 25, 2008 11:21:47 PM

Post# of 30387
WOW! It finally makes sense. I said he was recently in Europe, obviously about the patents, possibly also negotiating.
He was so fed up with Abbott that he waited until his RECAF patents in Europe were a done deal and then he told Abbott now there's a new sheriff in town. He got the leverage to prove that this is viable and will be worth billions, and after Abbott proved useless in providing us any clinical support(which now has come back to haunt them) he wants to get paid, and not with a check for a measly 50 grand.
Read what he is specificly saying.............
In our License agreements, 'granted' patent claims generate a
significantly higher royalty than 'pending' claims for any given country.

I'm not tooting my own horn, but I saw the writing on the wall about getting approval in Europe first.
Dr Moro says alot in this press release that gives me the utmost gratitude and confidence.
This particular statement is the most telling to me as to why no press releases or even a hint as to what he has been up to, especially this statement.............
``It is very important to understand the RECAF technology in detail in order to file patents based on the knowledge thus acquired. Pending approval of our patent, we have delayed publishing results in scientific journals since this would require us to supply extensive information so the studies can be reproduced by other scientists. Publishing certain critical information prior to receiving the approval for our patent would constitute 'prior art' that could interfere with the claim for a patent.'

In essence, any hint of this could have allowed other scientists to work toward a patent (ie Abbott) and stole it. That is why he preferred not to have his work published in any journals until he had the patents to prove it was his discovery.

AWESOME, DR M. I am very impressed.
He also recognizes that he is extending the life of the patents, so we could expect royalties for many more years.
"We are currently writing new patent applications based on the knowledge gained in the past two years. These patents -- which relate to the serum tests, the rapid tests and the RECAF chemistry in general -- should not only add value to BioCurex, but will also extend the patent protection provided by our current patents for the next two decades."

Lastly, he made a comment as if to apologize to shareholders, but gave good reasons for all the mystery and speculation that has literally plagued this stock for almost 4 years.
"We must keep thinking and acting with the long term benefit of the Company in mind; and we are thankful for the understanding and patient support of our shareholders. The efforts are paying off!``

This stock without that hedgefund would be several dollars. I am extremely content with this particular press release it answered most questions we have had over the last few years. He couldn't speak about any of this until it was a done deal. I also think the timing was good, because we now know why HE did what he did with Abbott and it was not the other way around. This good news means alot more today being separated from Thursday's news. We all said it was either a zero or our loterry ticket. Well, I think we just got another number correct and we are getting very close to the jackpot.
Congratulations to everyone who kept the faith.




Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.